CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of DYP688 as a single agent in patients with metastatic uveal melanoma (MUM) and other melanomas harboring GNAQ/11 mutations....
Phase 1, Phase 2
Boston, Massachusetts, United States and 10 other locations
CDX-301 and Nivolumab or Pembrolizumab as a possible treatment for melanoma.The names of the study drugs involved in this study are:* Person...
Phase 1
Boston, Massachusetts, United States
This research study is studying a targeted therapy called BVD-523 as a possible treatment for advanced uveal melanoma....
Phase 2
Boston, Massachusetts, United States and 1 other location
This research study involves studying a device as a possible treatment for metastatic melanoma in the brain. The purpose of this study is to...
Phase 1, Phase 2
Providence, Rhode Island, United States
This research study is studying a combination of drugs as a possible treatment for unresectable or metastatic melanoma.The drugs involved in...
Phase 2
Boston, Massachusetts, United States and 1 other location
therapy per local standard of care (SoC), best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma...
Phase 2, Phase 3
Boston, Massachusetts, United States and 70 other locations
binimetinib, and pembrolizumab) given together for the treatment of melanoma that:* is advanced or metastatic (spread to other parts of the ...
Phase 3
Boston, Massachusetts, United States and 227 other locations
This study observes the antitumor activity, safety, tolerability, PK, and pharmacodynamics in patients with inoperable and/or metastatic melanoma...
Phase 2
Boston, Massachusetts, United States and 43 other locations
treatment for metastatic or unresectable stage III or IV cutaneous melanoma.The names of the study drugs involved in this study are:* Atezol...
Phase 2
Boston, Massachusetts, United States and 2 other locations
tolerability, PK and antitumor activities of IN10018 as monotherapy and in combination with cobimetinib in subjects with metastatic uveal melanoma...
Phase 1
Boston, Massachusetts, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal